President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
Beginning in November, fully vaccinated international travelers will be able to enter the United States after months of travel restrictions. People under the age of 18 and those from countries without easy access to vaccines will not be required to be vaccinated but all travelers will need to show negative COVID test results before entering.
Apple could soon face a Department of Justice antitrust lawsuit after intensifying its probe into the tech giant, according to a report. The added scrutiny comes after the tech giant had already faced questioning in Washington and concluded an antitrust case brought by Epic Games.
Last week, shares of Digital World Acquisition Corp skyrocketed after following Former Present Trump's announcement that he would be partnering with the company as part of a Special Purpose Acquisition Company, or SPAC. Christian Munafo, Chief Investment Officer of Liberty Street Advisors and portfolio Manager of the Private Shares Fund broke down the latest, including whether or not Wall Street is currently experiencing a SPAC boom.
Jill and Carlo cover the news out of Facebook's latest earnings, Tesla's monumental day, Dave Chappelle addresses controversy and the tragedy of the climate emergency.
Stocks began the week on a high note, with two indexes - the Dow and the S&P 500 - each closing at a record high. Brian Levitt, Global Market Strategist at Invesco, joins Cheddar News' Closing Bell, where he explains why the conditions were in place for a jump during the session and provides insight on inflation concerns in the United States.
The price of Bitcoin hit a new all-time high last week following the Wall Street debut of ProShares Bitcoin Strategy ETF. Todd Cipperman, Founding Principal for Cipperman Compliance Services, joins Cheddar News' Closing Bell, where he explains why ProShares' ETF got off to a hot start while Valkyrie's Bitcoin Strategy ETF, which debuted just days later, did not.
Rishi Bharwani, the director of partnerships and policy for nonprofit Accountable Tech, joined Cheddar to discuss the hot button topic of regulatory oversight of social media giant Facebook. Bharwani discussed the bipartisan pieces of legislation already making their way through Congress and said the body should pass stronger data privacy laws, ban surveillance advertising, and require meaningful accountability and transparency from the company. "Now I think we've reached a boiling point where congressional action is needed and inaction is no longer acceptable," he said. Bharwani also called for a concurrent investigation into Mark Zuckerberg's company.
The United Nations COP26 climate talks are scheduled for October 31 to November 12 in Glasgow, Scotland. Heads of state will be joined by private sector leaders to once again discuss the shrinking window of time left to take action against global temperature rise. Barbara Humpton, CEO of focused technology company Siemens U.S., is also attending and spoke to Cheddar about what she hopes to see during the conference for both the public and private spheres. "What we are really urging is that there are large commitments made in Glasgow and that we really commit to this next decade of action," she said.
Jessica Mason Pieklo, Senior Vice President and Executive Editor at Rewire News Group and co-host of the Rewire News Group podcast, 'Boom! Lawyered,' joins Cheddar News to discuss the Supreme Court decision to hear Texas abortion ban cases on Monday, November first and the complicated timeline of legal challenges up to this point.
